NRX Pharmaceuticals Warrant (NRXPW)

• Market cap: $1.08M
• 1 day: 48%
• 5 days: 25%
• 1 month: -30.58%
• 3 months: 42.31%
• 6 months: -13.04%
• Year to date: -61.05%
• 1 year: -9.31%
• 5 years: -98.74%
• 10 years: -78.98%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.